Bristol Myers Squibb Change in Accounts Receivable 2010-2025 | BMY
Bristol Myers Squibb change in accounts receivable for the twelve months ending March 31, 2025 was $-0.140B, a 88.74% decline year-over-year.
- Bristol Myers Squibb annual change in accounts receivable for 2024 was $0.264B, a 126.53% decline from 2023.
- Bristol Myers Squibb annual change in accounts receivable for 2023 was $-0.995B, a 50.08% increase from 2022.
- Bristol Myers Squibb annual change in accounts receivable for 2022 was $-0.663B, a 37.1% decline from 2021.